𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The neurochemistry of therapeutics: Levodopa pharmacodynamics in Parkinson's disease

✍ Scribed by Kirk A. Frey

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
142 KB
Volume
49
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Accelerometric assessment of levodopa-in
Accelerometric assessment of levodopa-induced dyskinesias in Parkinson's disease
✍ J.I. Hoff; A.A. v/d Plas; E.A.H. Wagemans; J.J. van Hilten πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 1 views

Our objective was to develop parameters for objective ambulatory measurements of levodopa-induced dyskinesias (LID) in patients with Parkinson's disease (PD). Twentythree PD patients with mild to severe LID were submitted to a standardized protocol of 1-minute recordings during rest, talking, stress

Differential progression of motor impair
Differential progression of motor impairment in levodopa-treated Parkinson's disease
✍ Christopher G. Goetz; Glenn T. Stebbins; Lucy M. Blasucci πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 2 views

OBJECTIVE: To monitor comparative progression of clinical impairment over 4 years in patients with Parkinson's disease (PD) who present on levodopa at two different levels of Hoehn and Yahr (HY) stages, II and III. BACKGROUND: The rate of clinical impairment progression in patients with PD being tr